Sign In

Marc Rovner

Executive Advisor at Gryphon Investors

Marc Rovner is an experienced executive with a diverse background in consumer products, healthcare, and insurance industries. He currently serves as an Executive Advisory Board member at Gryphon Investors.4 Rovner's career highlights include:

  1. Former CEO of Matrixx Initiatives, a Gryphon portfolio company that produces over-the-counter cold remedies, including the Zicam brand.134

  2. Head of US Pet Healthcare for Boehringer-Ingelheim NA Animal Health, and previously General Manager for Boehringer-Ingelheim's US Consumer Healthcare business.4

  3. Managing Director at SmartAnalyst, where he tripled revenues by delivering strategic consulting projects to major clients like J&J, PepsiCo, and Pfizer.4

  4. CEO of Rovner & Company, LLC, a full-service insurance brokerage firm.25

Rovner has a BA with honors from the University of Pennsylvania and an MA from the University of Chicago, where he was a Noyes Fellow.4 His expertise in consumer health and business growth has made him a valuable asset to Gryphon Investors, where he assists in identifying and evaluating investment opportunities.6

Highlights

Jan 13 · gryphon-inv.com
Gryphon Executive Advisory Board
Gryphon Sells Zicam to Church & Dwight - Private Equity Professional
Dec 1 · prnewswire.com
Gryphon Investors Sells Matrixx, Maker of Zicam Cold Remedy ...
Dec 1 · gryphon-inv.com
Gryphon Investors Sells Matrixx, Maker of Zicam Cold Remedy ...

Related Questions

What are Marc Rovner's key achievements at Gryphon Investors?
How did Marc Rovner contribute to the growth of Zicam?
What other companies has Marc Rovner worked with?
What is Marc Rovner's background in the consumer health sector?
How did Marc Rovner's experience at Ernst & Young Kenneth Leventhal influence his career?
Marc Rovner
Add to my network

Location

White Plains, New York, United States